Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(8 sites)

France

Gustave Roussy, Villejuif, Val-de-Marne

Netherlands

Radboud University Medical Center, Nijmegen, Gelderland

Maastricht University Medical Center +, Maastricht, Limburg

The Netherlands Cancer Institute, Amsterdam, North Holland

Amsterdam University Medical Center, Amsterdam, North Holland

Leiden University Medical Center, Leiden, South Holland

Erasmus Medical Center, Rotterdam, South Holland

University Medical Center Groningen, Groningen